Questions Raised About Widely Used Blood-Brain Barrier Model
Questions Raised About Widely Used Blood-Brain Barrier Model
A study has sparked controversy by suggesting that cells made using a popular lab protocol have been misidentified, with potentially serious repercussions for brain research. Critics say the significance of the findings has been overstated.
Questions Raised About Widely Used Blood-Brain Barrier Model
Questions Raised About Widely Used Blood-Brain Barrier Model

A study has sparked controversy by suggesting that cells made using a popular lab protocol have been misidentified, with potentially serious repercussions for brain research. Critics say the significance of the findings has been overstated.

A study has sparked controversy by suggesting that cells made using a popular lab protocol have been misidentified, with potentially serious repercussions for brain research. Critics say the significance of the findings has been overstated.

neurodegenerative diseases
Biomarker Discovery with SMC<sup>TM</sup> Technology
Biomarker Discovery with SMCTM Technology
The Scientist Creative Services Team | Apr 6, 2021
Single Molecule Counting (SMC™) technology offers the sensitivity to reveal hidden biomarker information
First Alzheimer&rsquo;s Blood Test Rolled Out for Clinical Use in US
First Alzheimer’s Blood Test Rolled Out for Clinical Use in US
Shawna Williams | Nov 2, 2020
The test will be a cheaper and more accessible alternative to currently available diagnostic tools, researchers say.
The Scientist&#39;s LabTalk Podcast - Episode 2
The Scientist's LabTalk Podcast - Episode 2
The Scientist Creative Services Team | Oct 20, 2020
Surviving Stress: The mysteries of neuronal survival and neurodegeneration
Breaking Down Barriers
Breaking Down Barriers
The Scientist Creative Services Team | Oct 19, 2020
Looking at the future of neurodegeneration research!
Advancing Disease Research with Mass Spectrometry
Advancing Disease Research with Mass Spectrometry
The Scientist Creative Services Team | Sep 15, 2020
Explore just how indispensible mass spectrometry is becoming to life science researchers.
New Drug Combo for ALS Slows Decline in Small Clinical Study
New Drug Combo for ALS Slows Decline in Small Clinical Study
Jef Akst | Sep 3, 2020
After six months, patients with fast-progressing amyotrophic lateral sclerosis who had received the experimental treatment had less loss of function than those who received a placebo.
Flu and Pneumonia Vaccines Linked to Reduced Risk of Alzheimer&rsquo;s
Flu and Pneumonia Vaccines Linked to Reduced Risk of Alzheimer’s
Amanda Heidt | Jul 27, 2020
The authors propose that the shots might keep the immune system primed to battle diseases that would otherwise contribute to cognitive decline.
Astrocyte-to-Neuron Method Reverses Neurodegeneration in Mice
Astrocyte-to-Neuron Method Reverses Neurodegeneration in Mice
Ruth Williams | Jun 24, 2020
The cell conversion strategy restores neurons and motor functions lost as a result of an induced Parkinson’s-like illness in the animals.
Variants in Water Channel Gene Tied to More Restful Sleep
Variants in Water Channel Gene Tied to More Restful Sleep
Abby Olena | May 12, 2020
The gene, aquaporin-4, is critical in rodents for the cerebrospinal fluid bath the brain gets during sleep. It’s now also tied to slow wave electrical activity during deep sleep in people.